Cargando…

Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells

SIMPLE SUMMARY: Glioblastoma is one of the worst cancer types and the most common cancer originating within the brain. Patients afflicted by glioblastoma suffer from poor prognosis, a lack of specific therapies and frequent tumor recurrences. Many researchers are confident that glioblastoma cells ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Rehbein, Sarah, Possmayer, Anna-Lena, Bozkurt, Süleyman, Lotsch, Catharina, Gerstmeier, Julia, Burger, Michael, Momma, Stefan, Maletzki, Claudia, Classen, Carl Friedrich, Freiman, Thomas M., Dubinski, Daniel, Lamszus, Katrin, Stringer, Brett W., Herold-Mende, Christel, Münch, Christian, Kögel, Donat, Linder, Benedikt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648216/
https://www.ncbi.nlm.nih.gov/pubmed/37958423
http://dx.doi.org/10.3390/cancers15215249
_version_ 1785135288633262080
author Rehbein, Sarah
Possmayer, Anna-Lena
Bozkurt, Süleyman
Lotsch, Catharina
Gerstmeier, Julia
Burger, Michael
Momma, Stefan
Maletzki, Claudia
Classen, Carl Friedrich
Freiman, Thomas M.
Dubinski, Daniel
Lamszus, Katrin
Stringer, Brett W.
Herold-Mende, Christel
Münch, Christian
Kögel, Donat
Linder, Benedikt
author_facet Rehbein, Sarah
Possmayer, Anna-Lena
Bozkurt, Süleyman
Lotsch, Catharina
Gerstmeier, Julia
Burger, Michael
Momma, Stefan
Maletzki, Claudia
Classen, Carl Friedrich
Freiman, Thomas M.
Dubinski, Daniel
Lamszus, Katrin
Stringer, Brett W.
Herold-Mende, Christel
Münch, Christian
Kögel, Donat
Linder, Benedikt
author_sort Rehbein, Sarah
collection PubMed
description SIMPLE SUMMARY: Glioblastoma is one of the worst cancer types and the most common cancer originating within the brain. Patients afflicted by glioblastoma suffer from poor prognosis, a lack of specific therapies and frequent tumor recurrences. Many researchers are confident that glioblastoma cells can display traits of stem cells and that these attributes lead to an aggressive growth and high rate of recurrence. Based on our previous work that demonstrates that the “sun hormone” vitamin D(3) can block these stem cell traits, we have now gained additional insights into the effects of the active form of vitamin D(3), calcitriol. We can show that specific gene variants of the vitamin D(3) receptor might be responsible for the sensitivity towards calcitriol and that sensitive cells are blocked in their stemness attributes as well as migratory potential. ABSTRACT: Glioblastoma is the most common primary brain cancer in adults and represents one of the worst cancer diagnoses for patients. Suffering from a poor prognosis and limited treatment options, tumor recurrences are virtually inevitable. Additionally, treatment resistance is very common for this disease and worsens the prognosis. These and other factors are hypothesized to be largely due to the fact that glioblastoma cells are known to be able to obtain stem-like traits, thereby driving these phenotypes. Recently, we have shown that the in vitro and ex vivo treatment of glioblastoma stem-like cells with the hormonally active form of vitamin D(3), calcitriol (1α,25(OH)(2)-vitamin D(3)) can block stemness in a subset of cell lines and reduce tumor growth. Here, we expanded our cell panel to over 40 different cultures and can show that, while half of the tested cell lines are sensitive, a quarter can be classified as high responders. Using genetic and proteomic analysis, we further determined that treatment success can be partially explained by specific polymorphism of the vitamin D(3) receptor and that high responders display a proteome suggestive of blockade of stemness, as well as migratory potential.
format Online
Article
Text
id pubmed-10648216
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106482162023-10-31 Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells Rehbein, Sarah Possmayer, Anna-Lena Bozkurt, Süleyman Lotsch, Catharina Gerstmeier, Julia Burger, Michael Momma, Stefan Maletzki, Claudia Classen, Carl Friedrich Freiman, Thomas M. Dubinski, Daniel Lamszus, Katrin Stringer, Brett W. Herold-Mende, Christel Münch, Christian Kögel, Donat Linder, Benedikt Cancers (Basel) Article SIMPLE SUMMARY: Glioblastoma is one of the worst cancer types and the most common cancer originating within the brain. Patients afflicted by glioblastoma suffer from poor prognosis, a lack of specific therapies and frequent tumor recurrences. Many researchers are confident that glioblastoma cells can display traits of stem cells and that these attributes lead to an aggressive growth and high rate of recurrence. Based on our previous work that demonstrates that the “sun hormone” vitamin D(3) can block these stem cell traits, we have now gained additional insights into the effects of the active form of vitamin D(3), calcitriol. We can show that specific gene variants of the vitamin D(3) receptor might be responsible for the sensitivity towards calcitriol and that sensitive cells are blocked in their stemness attributes as well as migratory potential. ABSTRACT: Glioblastoma is the most common primary brain cancer in adults and represents one of the worst cancer diagnoses for patients. Suffering from a poor prognosis and limited treatment options, tumor recurrences are virtually inevitable. Additionally, treatment resistance is very common for this disease and worsens the prognosis. These and other factors are hypothesized to be largely due to the fact that glioblastoma cells are known to be able to obtain stem-like traits, thereby driving these phenotypes. Recently, we have shown that the in vitro and ex vivo treatment of glioblastoma stem-like cells with the hormonally active form of vitamin D(3), calcitriol (1α,25(OH)(2)-vitamin D(3)) can block stemness in a subset of cell lines and reduce tumor growth. Here, we expanded our cell panel to over 40 different cultures and can show that, while half of the tested cell lines are sensitive, a quarter can be classified as high responders. Using genetic and proteomic analysis, we further determined that treatment success can be partially explained by specific polymorphism of the vitamin D(3) receptor and that high responders display a proteome suggestive of blockade of stemness, as well as migratory potential. MDPI 2023-10-31 /pmc/articles/PMC10648216/ /pubmed/37958423 http://dx.doi.org/10.3390/cancers15215249 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rehbein, Sarah
Possmayer, Anna-Lena
Bozkurt, Süleyman
Lotsch, Catharina
Gerstmeier, Julia
Burger, Michael
Momma, Stefan
Maletzki, Claudia
Classen, Carl Friedrich
Freiman, Thomas M.
Dubinski, Daniel
Lamszus, Katrin
Stringer, Brett W.
Herold-Mende, Christel
Münch, Christian
Kögel, Donat
Linder, Benedikt
Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells
title Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells
title_full Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells
title_fullStr Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells
title_full_unstemmed Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells
title_short Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells
title_sort molecular determinants of calcitriol signaling and sensitivity in glioma stem-like cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648216/
https://www.ncbi.nlm.nih.gov/pubmed/37958423
http://dx.doi.org/10.3390/cancers15215249
work_keys_str_mv AT rehbeinsarah moleculardeterminantsofcalcitriolsignalingandsensitivityingliomastemlikecells
AT possmayerannalena moleculardeterminantsofcalcitriolsignalingandsensitivityingliomastemlikecells
AT bozkurtsuleyman moleculardeterminantsofcalcitriolsignalingandsensitivityingliomastemlikecells
AT lotschcatharina moleculardeterminantsofcalcitriolsignalingandsensitivityingliomastemlikecells
AT gerstmeierjulia moleculardeterminantsofcalcitriolsignalingandsensitivityingliomastemlikecells
AT burgermichael moleculardeterminantsofcalcitriolsignalingandsensitivityingliomastemlikecells
AT mommastefan moleculardeterminantsofcalcitriolsignalingandsensitivityingliomastemlikecells
AT maletzkiclaudia moleculardeterminantsofcalcitriolsignalingandsensitivityingliomastemlikecells
AT classencarlfriedrich moleculardeterminantsofcalcitriolsignalingandsensitivityingliomastemlikecells
AT freimanthomasm moleculardeterminantsofcalcitriolsignalingandsensitivityingliomastemlikecells
AT dubinskidaniel moleculardeterminantsofcalcitriolsignalingandsensitivityingliomastemlikecells
AT lamszuskatrin moleculardeterminantsofcalcitriolsignalingandsensitivityingliomastemlikecells
AT stringerbrettw moleculardeterminantsofcalcitriolsignalingandsensitivityingliomastemlikecells
AT heroldmendechristel moleculardeterminantsofcalcitriolsignalingandsensitivityingliomastemlikecells
AT munchchristian moleculardeterminantsofcalcitriolsignalingandsensitivityingliomastemlikecells
AT kogeldonat moleculardeterminantsofcalcitriolsignalingandsensitivityingliomastemlikecells
AT linderbenedikt moleculardeterminantsofcalcitriolsignalingandsensitivityingliomastemlikecells